Vanderbilt Autonomic Dysfunction Center

Norepinephrine Transporter Deficiency

Our understanding of orthostatic intolerance was greatly expanded in 2000 when norepinephrine transporter (NET) deficiency was reported. In a proband with significant orthostatic symptoms and tachycardia, we found:

  • Disproportionately elevated plasma norepinephrine with standing
  • Impaired systemic and local clearance of infused tritiated norepinephrine
  • Impaired tyramine responsiveness
  • Dissociation between stimulated plasma NE and DHPG (an intraneuronal metabolite of NE) elevation.

Studies of NET gene structure in the proband revealed a coding mutation which converts a highly conserved transmembrane domain Ala residue to Pro. Analysis of the protein produced by the mutant cDNA in transfected cells demonstrated greater than 98% reduction in activity relative to normal. Studies of the proband and her family revealed correlations of plasma NE, DHPG/NE, and heart rate with the mutant allele. These results represent the first identification of a specific genetic defect in OI and the first disease linked to a coding alteration in a Na+/Cl- dependent neurotransmitter transporter. Identification of this mechanism may facilitate our understanding of genetic causes of OI and lead to the development of more effective therapeutic modalities.

This page was last updated March 9, 2016 and is maintained by